Schedule 13G: Alyeska Reports 1.36M HNGE Shares, 5.51% Ownership

Rhea-AI Filing Summary

Hinge Health, Inc. Schedule 13G shows Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh jointly report beneficial ownership of 1,363,061 shares of the issuer's Class A common stock, representing 5.51% of the outstanding class. The filing states these shares are held with shared voting and dispositive power and that the percentage is calculated using 24,749,541 outstanding shares from the issuer's 8-A12B filed May 19, 2025. The signatories certify the holdings were acquired and are held in the ordinary course of business.

Positive

• Material disclosure: Reporting persons publicly disclose a 5.51% stake (1,363,061 shares), crossing the SEC 5% threshold.
• Joint filing clarity: The Schedule 13G includes a joint filing statement under Rule 13d-1(k), clarifying shared responsibility for amendments.
• Certifies ordinary-course holding: Signatories state the shares are held in the ordinary course of business and not to influence control.

Negative

• None.

Insights

Financial Analyst

TL;DR Alyeska reports a meaningful 5.51% stake in Hinge Health, a position that is material to holders and market observers.

The filing discloses a joint beneficial ownership of 1,363,061 Class A shares, with shared voting and dispositive power. The stake equals 5.51% based on 24,749,541 shares outstanding per the issuer's May 19, 2025 8-A12B. This level of ownership crosses the 5% reporting threshold, making the position publicly visible and subject to regulatory disclosure requirements. The certification indicates the position is held in the ordinary course of business.

Corporate Governance Expert

TL;DR A joint Schedule 13G filing signals a passive, disclosed >5% holding with shared voting authority among the reporting parties.

The document is a Rule 13d-1 filing listing Alyeska entities and Anand Parekh as reporting persons, each reporting identical shared voting and dispositive power over the 1,363,061 shares. The joint filing statement under Rule 13d-1(k) confirms collective responsibility for disclosures. The signatories assert the securities were not acquired to influence control, consistent with Schedule 13G use for passive investors.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Hinge Health, Inc.

(Name of Issuer)

Class A Common Stock, $0.00001 par value

(Title of Class of Securities)

433313103

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,363,061.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,363,061.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,363,061.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.51 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,363,061.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,363,061.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,363,061.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.51 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,363,061.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,363,061.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,363,061.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.51 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health, Inc.
(b)	Address of issuer's principal executive offices: 455 Market Street, Suite 700, San Francisco, California 94105
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Class A Common Stock, $0.00001 par value
(e)	CUSIP No.: 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,363,061
(b)	Percent of class: 5.51%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,363,061
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,363,061
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2025

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	08/14/2025

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	08/14/2025

Exhibit Information

Item 4. Ownership: The reporting persons are the beneficial owners of 1,363,061 shares of the Issuer's Class A Common Stock, $0.00001 par value. The percentage calculation assumes that there are currently 24,749,541 outstanding shares of Common Stock of the Issuer, based on the Issuer's 8-A12B filed with the Securities and Exchange Commission on May 19, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

FAQ

How many HNGE shares does Alyeska report owning?

The reporting persons state beneficial ownership of 1,363,061 shares of Hinge Health Class A common stock.

What percentage of Hinge Health (HNGE) does the filing represent?

The filing reports ownership equal to 5.51% of the outstanding Class A shares, based on 24,749,541 shares outstanding.

Do the reporting persons have voting power over the HNGE shares?

Yes, the filing states they have shared voting power and shared dispositive power over all 1,363,061 shares; no sole power is reported.

Was the position acquired to influence control of Hinge Health (HNGE)?

The signatories certify the securities were acquired and are held in the ordinary course of business and not to change or influence control.

Who signed the Schedule 13G for Alyeska and Anand Parekh?

Jason Bragg signed for Alyeska Investment Group, L.P. and Alyeska Fund GP, LLC as Chief Financial Officer; Anand Parekh signed for himself.